TurboVets is fully live. For support, please submit tickets in app.
Sign In to TurboVets
Your Data is Protected. Never Sold. Never Used for Profit.
Read our FAQ
7824
§ 4.118 Schedule of ratings—skin.

Skin thickening disorders

Skin disorders causing abnormal thickening, scaling, or hardening of the skin.

What the rating means

Diseases of keratinization — including conditions such as ichthyoses, Darier's disease, and palmoplantar keratoderma — are rated under the General Rating Formula for the Skin at 60%, 30%, 10%, or 0%.

The 60% rating applies when characteristic lesions cover more than 40 percent of your entire body or more than 40 percent of exposed areas, or when systemic therapy has been required constantly or near-constantly over the past 12 months. The 30% rating applies when lesions cover 20 to 40 percent of your entire body or exposed areas, or when systemic therapy was needed for a total of 6 weeks or more — but not constantly — over the past 12 months. The 10% rating applies when lesions cover at least 5 percent but less than 20 percent of your entire body or exposed areas, or when intermittent systemic therapy was needed for less than 6 weeks total over the past 12 months. The 0% rating applies when no more than topical therapy was needed and lesions cover less than 5 percent of your entire body or exposed areas.

Systemic therapy means treatment given orally, by injection, by suppository, or intranasally — not applied directly to the skin.

Evidence that helps

Medical records that document the percentage of your body surface or exposed areas affected by characteristic lesions are central to this rating. A dermatologist's examination notes that estimate or measure affected skin area — whether on your entire body or on areas typically visible, such as your face, hands, and arms — directly support the body-surface criteria at each level.

Treatment records are equally important. For the 60% level, records showing that systemic therapy such as oral corticosteroids, retinoids, biologics, phototherapy, PUVA, or other immunosuppressive drugs was required constantly or near-constantly over the past 12 months carry significant weight. For the 30% level, pharmacy records, prescription histories, or clinic notes showing at least 6 cumulative weeks of such therapy — though not constant — over the past 12 months support that tier. For the 10% level, similar records showing less than 6 total weeks of intermittent systemic therapy are relevant.

Statements from you or people who know you that describe how your skin condition affects your daily activities — such as limitations in exposure to sunlight, difficulties with physical tasks, or the time burden of treatment — can help show the ongoing nature and severity of your condition alongside the clinical records.

Secondary conditions

Conditions that are often caused or made worse by this one. If you have any of these, they may be claimable as secondary service connection.